A randomized trial of cognitive behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia / Franske J. van Apeldoorn en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 5 (Mayo) . - pp. 574-586 Título : A randomized trial of cognitive behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia : treatment results through 1 year follow up Tipo de documento: texto impreso Autores: Franske J. van Apeldoorn, Autor ; Marieke E. Timmerman, Autor ; Peter Paul A. Mersch, Autor Fecha de publicación: 2022 Artículo en la página: pp. 574-586 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agorafobia, Terapia cognitiva conductual, Terapia de modalidad combinada, Trastorno de pánico, Calidad de vida. Resumen: To establish the long-term effectiveness of 3 treatments for DSM-IV panic disorder with or without agoraphobia: cognitive-behavioral therapy (CBT), pharmacotherapy using a selective serotonin reuptake inhibitor (SSRI), or the combination of both (CBT + SSRI). As a secondary objective, the relationship between treatment outcome and 7 predictor variables was investigated. Link: ./index.php?lvl=notice_display&id=28187 [artículo] A randomized trial of cognitive behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia : treatment results through 1 year follow up [texto impreso] / Franske J. van Apeldoorn, Autor ; Marieke E. Timmerman, Autor ; Peter Paul A. Mersch, Autor . - 2022 . - pp. 574-586. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 5 (Mayo) . - pp. 574-586 Palabras clave: Agorafobia, Terapia cognitiva conductual, Terapia de modalidad combinada, Trastorno de pánico, Calidad de vida. Resumen: To establish the long-term effectiveness of 3 treatments for DSM-IV panic disorder with or without agoraphobia: cognitive-behavioral therapy (CBT), pharmacotherapy using a selective serotonin reuptake inhibitor (SSRI), or the combination of both (CBT + SSRI). As a secondary objective, the relationship between treatment outcome and 7 predictor variables was investigated. Link: ./index.php?lvl=notice_display&id=28187

---

1 (1 - 1 / 1)